Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Ovarian Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Anhui Cancer Hospitail, Hefei, Anhui, China
Contact: Study coordinator (Bai-Rong Xia, Doctor) · xiabairong9999@126.com · +8118604516165
Study coordinator · xiabairong9999@126.com

Study leads

Bai-Rong Xia, Doctor
Study Chair
Anhui Provincial Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Maywood, United States

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Tucson, United States

Study of AVZO-021 in Patients With Advanced Solid Tumors

Advanced Solid Tumor · HR+/HER2- Breast Cancer · HR+, HER2-, Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

New Haven, United States · Sarasota, United States

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Ovarian Cancer

Abroad (travel likely)RecruitingPHASE2

Hefei, China